期刊文献+

AMD3100促进载脂蛋白E^(-/-)小鼠动脉粥样硬化斑块形成 被引量:2

AMD3100 Aggravates Apolipoprotein E^(-/-) Mice Atherosclerosis Plaque Formation
下载PDF
导出
摘要 目的探讨AMD3100对载脂蛋白E-/-小鼠主动脉动脉粥样硬化斑块形成的影响及其可能机制。方法12只8周龄雄性载脂蛋白E-/-小鼠随机分为AMD3100组(2.5mg/kg,隔天注射)和对照组(PBS 0.1mL,隔天注射),高脂高胆固醇饲料喂养12周后,获取组织标本和骨髓细胞,石蜡切片HE染色检测小鼠主动脉根部动脉粥样硬化病变;通过计数典型内皮祖细胞克隆形成单位和观察次级集落单位的大小与细胞密度检测内皮祖细胞的克隆形成能力;逆转录聚合酶链反应和Western blotting检测内皮祖细胞CXCR4 mRNA和蛋白的表达。结果AMD3100组小鼠主动脉窦横切面粥样斑块面积与管腔面积之比与对照组比较增加了38.8%(37.2%±3.6%比26.8%±2.5%,P<0.05);AMD3100组小鼠骨髓源内皮祖细胞的克隆形成能力显著低于对照组(初级内皮祖细胞集落单位个数为9.67±2.16比21.83±2.64,次级内皮祖细胞集落单位个数为1.67±0.31比4.11±0.65,P<0.01);AMD3100组CXCR4 mRNA和蛋白的表达均显著低于对照组(P<0.01)。结论AMD3100促进载脂蛋白E-/-小鼠动脉粥样硬化斑块形成,可能与抑制骨髓源内皮祖细胞的克隆形成并下调CXCR4表达相关。 Aim To study the effects of AMD3100 on atherosclerosis and the possible mechanism in apolipoprotein E^-/- mice, Methods 12 male apolipoprotein E^-/- mice, 8 weeks old, were randomly divided into two groups: AMD3100 group (2.5 mg/kg, the next day intraperitoneal injection) and control group (PBS 0.1 mL, the next day intraperitoneal injection), After fed with high fat and cholesterol western food for 12 weeks, all mice tissue specimen and bone marrow cells were harvested. The Hematoxylin/Eosin staining of paraffin section was performed to detect atherosclerotic plaque of aortic root. By counting the typical endothelial progenitor cells-colony forming units (EPC-CFU) and observing the size and cell density of secondary EPC-CFU, the clonality of endothelial progenitor cells was measured. The expression of CXCR4 mRNA and protein were examined by RT-PCR and Western blotting. Results Compared with control group, the area percentage of atherosclerotic lesion and vessel lumina increased 38.8% in AMD3100 treated apolipoprotein E^-/- mice (37.2% ± 3.6% vs 26.8% ± 2.5%, P 〈 0.05). The clonality of endothelial progenitor cells derived from AMD3100 group decreased in comparison to control group (primary EPC-CFU: 9.67±2.16vs21.83±2.64, secondary EPC-CFUs: 1.67±0.31 vs4.11±0.65;P〈0.01). The expression of CXCR4 mRNA and protein of AMD3100 group were also reduced ( P 〈 0.01 ). Conclusions The atherosclerotic lesion was aggravated by administration of AMD3100 in apolipoprotein E^-/- mice. Possible mechanism of this action for AMD3100 are associated with the inhibition of the clonality of bone marrow endothelial progenitor cells and down-regulatipon of CXCR4 expression on endothelial progenitor cells.
作者 周晓峰 王佐
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第6期445-448,共4页 Chinese Journal of Arteriosclerosis
基金 中国博士后基金(2005038472) 湖南省自然科学基金(07jj3034) 湖南省教育厅课题(07C617)
关键词 病理学与病理生理学 AMD3100 动脉粥样硬化 内皮祖细胞 CXCR4 克隆形成单住 AMD3100 Atherosclerosis Endothelial Progenitor Cells Colony Forming Units
  • 相关文献

参考文献14

  • 1Sakiham,a H, Masuraga T, Yamashita K, et al. Stromal Cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis [ J]. Circulation, 2004, 1111 (18) : 2 924-930.
  • 2Damas JK, Waehre T, Yndestad A, et al. Stromal cell-derived factor-1 in unstable angina potential antiinflammatory and matrix stabilizing effects [ J]. Circulation, 2002, 106 (1) : 36-42.
  • 3Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of marine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J]. J Exp Med, 2005, 201 (8) : 1 307-318.
  • 4Matthys P,Hatse S,Vermeire k,et al.AMD3100,a potent and specific atagonist of the tromal cell-derived factor-1 chemokine receptro cxcr4,inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice[J].J Immunol,2001,167(8):4686-692.
  • 5王佐,童中艺,周晓峰,姜志胜,唐朝克,宋砚明,田永凤.微孔法分离大鼠骨髓内皮祖细胞[J].生物化学与生物物理进展,2007,34(7):754-759. 被引量:10
  • 6Zemecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/ CXC ligand 12 unveil8 the importance of neutrophils in atherosclerosis [ J]. Circ Res, 2008, 102 (2) : 209-217.
  • 7Suratt BT, Petty JM, Young SK, et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis[J]. Blood, 2004, 104 (2): 565- 571.
  • 8Massberg S, Konard I, Schurzinger K, et al. Platelets secrete stromal cell derived factor 1α and recruit bone marrow-derived pragenitor cells to arterial thrombi invivo[J]. J Expl Med, 2006, 2113(5): 1221-233.
  • 9Werner N, Kosiol S, Schiegl T, et al. Ciculating endothelial progenitor cells and cardiovascular outcomes [ J ]. N Engl J Med, 2005,353(10):999-1 007.
  • 10Shantsila E, Watson T, Tse HF, et al. Endothelial colony forming units: are they a reliable marker of endothelial progenitor cen numbers [ J] ? Ann Med, 2007, 39 (6): 474-479.

二级参考文献34

  • 1杨文博.趋化因子基质细胞衍生因子1(SDF-1)及其受体CXCR4[J].免疫学杂志,2003,19(S1):142-144. 被引量:15
  • 2张威,周莉,金惠铭,曲晓义,张国平,殷莲华,朱大年.用CD133免疫磁珠分离脐血内皮祖细胞的实验研究[J].中国病理生理杂志,2005,21(9):1675-1680. 被引量:7
  • 3王佐,童中艺,周晓峰,姜志胜,唐朝克,宋砚明,田永凤.微孔法分离大鼠骨髓内皮祖细胞[J].生物化学与生物物理进展,2007,34(7):754-759. 被引量:10
  • 4Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275: 964-967
  • 5Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34- cells identifies a population of functional endothelial precursors. Blood, 2000, 95:952-958
  • 6Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001, 89: e1 -e7
  • 7Ito M, Matsubara K, Matsubara Y. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol, 2006, 56:79-85
  • 8Hill J M, Zalos G, Halcox J P, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348:593-600
  • 9Aoki M, Yasutake M, Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells, 2004, 22 (6): 994- 1002
  • 10Paola R, Francesco A, Francesco L, et al. CD14^+ CD341ow cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res, 2005, 97 (4): 314-322

共引文献13

同被引文献32

  • 1苏靖,刘瑶,郑志兵,李松.Plerixafor的合成[J].中国医药工业杂志,2007,38(6):398-400. 被引量:5
  • 2袁源智,袁非,黎蕾,汪洋,童蓓燕.基质细胞衍生因子-1在Wistar大鼠视网膜上的生理性表达[J].眼科研究,2007,25(7):518-521. 被引量:8
  • 3Steinberg D.Atherogenesis in perspective:Hypercholesterolemia and inflammation as partners in crime.Nat Med,2002,8(11):1211-1217.
  • 4Libby P.Inflammation in atherosclerosis.Nature,2002,420(6):868-874.
  • 5Abi-Younes S,Sauty A,Mach F,et al.The stromal cell-derived factor-1chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.Circ Res,1999,86(2):131-138.
  • 6Schober A,Knarren S,Lietz M,et al.Crucial role of stromal cell-derived factor-1αin neointima formation after vascular injuryin apolipoprotein E-deficient mice.Circulation,2003,108(2):491-497.
  • 7Sakihama H,Masunaga T,Yamashita K,et al.Stromal cell-derived factor-1and CXCR4interaction is critical for development of transplant arteriosclerosis.Circulation,2004,110(18):2924-2930.
  • 8Dams J K,Waehre T,Yndestad A,et al.Stromal cell derived factor-1in unstable angina potential antiinflammatory and matrix stabilizing effects.Circulation,2002,106(1):36-42.
  • 9Weintraub W S,Harrison D G.C reactive protein,inflammation and atherosclerosis:Do we really understand it yet?.Eur Heart J,2000,21(12):958-960.
  • 10Belton O,Byrne D,Kearney D,et al.Cyclooxygenase-1and-2-dependent prostacyclin formation in patients with atherosclerosis.Circulation,2000,102(8):840-845.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部